treating adults treating adhd Adderall shortage

ADHD Medication Prescriptions Spiked Ahead of Adderall Shortage: New Report

Reading now: 652

January 17, 2024Prescriptions for ADHD medications increased significantly during the COVID-19 pandemic, especially for women and for adults aged 20-39, according to a new study published in JAMA Psychiatry.

The most significant increases were found among prescriptions for adults aged 20-39, up 81% for non-stimulants and 30% for stimulants; and for women, up 59% for non-stimulants and 25% for stimulants.1 By contrast, researchers found a decrease or no change in rates of prescriptions during the pandemic for medications used to treat other behavioral health disorders, including anxiety, depression, and opioid use disorders.The researchers, associated with the U.S.

Food and Drug Administration (FDA), sought to explore how the pandemic altered patterns of behavioral health treatment within the U.S.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles
Live Webinar on February 28: Eating Disorders Comorbid with ADHD: What You Need to Know About ARFID, Anorexia, and Others
Not available February 28? Don’t worry. Register now and we’ll send you the replay link to watch at your convenience.Eating disorders are serious mental health conditions that often go undetected and untreated. An estimated 28 million Americans will struggle with an eating disorder at some point in their lifetime, but only some of these individuals will receive the care they need. Given the high rate of comorbidity between eating disorders and ADHD, it’s important for families, caregivers, and individuals with ADHD to be well-informed about the symptoms and treatments for different types of eating disorders. This is particularly true for diagnoses that are relatively new or understudied like atypical anorexia nervosa and avoidant/restrictive food intake disorder (ARFID).In this webinar you will learn:Have a question for our expert? There will be an opportunity to post questions for the presenter during the live webinar.Dr. Christine Peat is the Director of the National Center of Excellence for Eating Disorders (NCEED) and an Associate Professor of Psychiatry at the University of North Carolina at Chapel Hill. As the Director of NCEED, Dr. Peat is focused on broadly disseminating education and training on eating disorders to healthcare providers across a variety of disciplines. Her scientific research has focused on evidence-based treatments for eating disorders and the physiological comorbidities associated with these conditions.Dr. Peat is also a licensed psychologist in North Carolina and continues to be an active clinician at UNC serving patients with eating disorders, supporting healthcare providers in the UNC Wellbeing Program, and providing behavioral medicine interventions to patients in various medical settings.